IL6 and Hypertension: On linear regression, 2-Methylbutyrate was the most predictive SCFA for systemic IL-6 levels, while Butyrate was the most predictive of intracranial IL-6 levels, and the strength of both models improved when hypertension was included as a predictor in the models.